ABATACEPT TREATMENT REDUCES DISEASE ACTIVITY IN EARLY PRIMARY SJOGREN'S SYNDROME (PHASE II OPEN LABEL ASAP STUDY)

P. Meiners; A. Vissink; F. Kroese; F. Spijkervet; E. Haacke; W. Abdulahad; N. Sillevis Smitt-Kamminga; E. Brouwer; S. Arends; H. Bootsma

ABATACEPT TREATMENT REDUCES DISEASE ACTIVITY IN EARLY PRIMARY SJOGREN'S SYNDROME (PHASE II OPEN LABEL ASAP STUDY)

P. Meiners, A. Vissink, F. Kroese, F. Spijkervet, E. Haacke, W. Abdulahad, N. Sillevis Smitt-Kamminga, E. Brouwer, S. Arends, H. Bootsma

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	89-89
Number of pages	1
Journal	Annals of the Rheumatic Diseases
Volume	72
Publication status	Published - Jun-2013

Handle.net

Persistent link

Cite this

@article{265aa5fa462e4486828d95f9558673ef,

title = "ABATACEPT TREATMENT REDUCES DISEASE ACTIVITY IN EARLY PRIMARY SJOGREN'S SYNDROME (PHASE II OPEN LABEL ASAP STUDY)",

author = "P. Meiners and A. Vissink and F. Kroese and F. Spijkervet and E. Haacke and W. Abdulahad and Smitt-Kamminga, \{N. Sillevis\} and E. Brouwer and S. Arends and H. Bootsma",

year = "2013",

month = jun,

language = "English",

volume = "72",

pages = "89--89",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - ABATACEPT TREATMENT REDUCES DISEASE ACTIVITY IN EARLY PRIMARY SJOGREN'S SYNDROME (PHASE II OPEN LABEL ASAP STUDY)

AU - Meiners, P.

AU - Vissink, A.

AU - Kroese, F.

AU - Spijkervet, F.

AU - Haacke, E.

AU - Abdulahad, W.

AU - Smitt-Kamminga, N. Sillevis

AU - Brouwer, E.

AU - Arends, S.

AU - Bootsma, H.

PY - 2013/6

Y1 - 2013/6

M3 - Meeting Abstract

SN - 0003-4967

VL - 72

SP - 89

EP - 89

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

ER -